Protection From Cisplatin Ototoxicity by Lactated Ringers

Withdrawn before enrolling · Phase 1

Conditions studied: Hearing Loss

In brief

The purpose of this study is to determine if Lactated Ringer's solution is effective in patients undergoing chemotherapy with cisplatin for head and neck cancer in regards to cisplatin-induced hearing loss.

Key facts

Study ID

NCT00584155

Run by

University of Oklahoma

People needed

0

Starts

2006-07-01

Expected to finish

2010-06-01

Last updated by the study team

2015-05-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with cancer to be treated with cisplatin.
• Patients expected to receive a minimum of 3 rounds of chemotherapy.
• Patients receiving a minimum dose of cisplatin of 70 mg/m2

You may not qualify if…

• Patients who have had middle ear surgery.
• Patients who have active external or middle ear disease
• Patients who have preceding pure tone average of >40 dB HL

Where it is running

• University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.